menu
    • menu

    Company profile for Shaperon

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    What we do : New Approach to Inflammatory Diseases (Small Molecule)- Based on deep understanding of DAMPs (Damage Associated Molecular Patterns). Targeting multi-modal, complex inflammatory diseases. Developing immune modulating molecules with strong efficacy and excellent safety profiles. Next Generation NanoMAb® Technology. Based on a wide array of nanobody libraries from immunized camelid. Focusing on new antigen ta...
    What we do : New Approach to Inflammatory Diseases (Small Molecule)- Based on deep understanding of DAMPs (Damage Associated Molecular Patterns). Targeting multi-modal, complex inflammatory diseases. Developing immune modulating molecules with strong efficacy and excellent safety profiles. Next Generation NanoMAb® Technology. Based on a wide array of nanobody libraries from immunized camelid. Focusing on new antigen targets. Developing nanobody-based cancer therapeutics with high affinity and low immunogenicity. From bispecific nanobodies to genetically conjugated Nanotoxin®. High-throughput cell line development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Shaperonkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    Suite 606 Gangnam Ace Tower G9, 174-10 Jagok-ro, Gangnam-gu Seoul 06373,
    Telephone
    Telephone
    (82)2.6083.8315
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://shaperon.com/eng/main/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Shaperon Attends 7th Inflammasome Therapeutics Summit in Boston
    Shaperon Attends 7th Inflammasome Therapeutics Summit in Boston

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113583652/en/Shaperon-Attends-7th-Inflammasome-Therapeutics-Summit-in-Boston-CEO-Dr.-Seungyong-Seong-Delivers-Keynote-Presentation-on-GPCR19-Targeted-Drug-Development

    BUSINESSWIRE
    13 Nov 2025
    Share Share
    Hudson Therapeutics, U.S. Subsidiary of Shaperon, Starts NuGel
    Hudson Therapeutics, U.S. Subsidiary of Shaperon, Starts NuGel

    10 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250310186082/en

    BUSINESSWIRE
    10 Mar 2025
    Share Share
    Hudson Therapeutics And Shaperon Pursue Global Licensing Partners
    Hudson Therapeutics And Shaperon Pursue Global Licensing Partners

    07 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241006658150/en

    BUSINESSWIRE
    07 Oct 2024
    Share Share
    Hudson And Shaperon Seek Global Licensing At Q4 Conferences
    Hudson And Shaperon Seek Global Licensing At Q4 Conferences

    06 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241006658150/en

    BUSINESSWIRE
    06 Oct 2024
    Share Share
    Hudson Therapeutics Enters Alopecia Areata Market
    Hudson Therapeutics Enters Alopecia Areata Market

    26 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240926364462/en

    BUSINESSWIRE
    26 Sep 2024
    Share Share
    Korean firms Shaperon and Dong-A ST sign MoU for nanobody-based NDD
    Korean firms Shaperon and Dong-A ST sign MoU for nanobody-based NDD

    12 Jun 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/26/24412/korean-firms-shaperon-and-dong-a-st-sign-mou-for-nanobody-based-new-drug-development.html

    BIOSPECTRUM ASIA
    12 Jun 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search